REFERENCE
GlaxoSmith Kline.GlaxoSmithKline would like to advise you of a recent update to the RELENZA (zanamivir) Inhalation Powder package insert. Internet Document: [3 pages], 11 Mar 2008. Available from: URL: http://www.fda.gov
Rights and permissions
About this article
Cite this article
Relenza label updated. React. Wkly. 1197, 2 (2008). https://doi.org/10.2165/00128415-200811970-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200811970-00002